Longevity tech for fashion executives is no longer a niche curiosity: it is fast becoming a category that luxury and lifestyle brands cannot afford to ignore. Vogue Business is hosting a live webinar on 10 September to map the terrain, with technology editor Amy O’Brien joined by Whoop founder and CEO Will Ahmed and Prenuvo founder and CEO Andrew Lacy.
The numbers behind the category are, depending on which research house you ask, somewhere between very large and enormous. The snippet puts the global health check-up market at $79.2 billion by 2030. Mordor Intelligence arrives at a higher figure: a baseline of $59.3 billion in 2025, growing at a 6.60% CAGR to reach $85.5 billion by 2030. The discrepancy reflects different methodologies and dataset boundaries, though both trajectories point in the same direction.
The wearable AI figures are similarly contested. One projection puts the segment at $310.6 billion by 2033. Polaris Market Research extends the horizon slightly further, projecting $342.36 billion by 2034 at a 17.55% CAGR, with North America holding a 38.6% share. The broader digital health market, per MarketsandMarkets, is expected to climb from $199.14 billion in 2025 to $573.53 billion by 2030 at a 23.6% CAGR.
Why Longevity Tech for Fashion Executives Matters Now
The investment flowing into the category is not speculative froth. WHOOP, one of the session’s featured companies, closed a $575 million Series G round in March 2026, lifting its valuation to $10.1 billion, according to MobiHealthNews. That compares with a $3.6 billion valuation on its Series F in 2021, meaning the company roughly tripled in five years while most consumer tech was contracting.
Prenuvo, the full-body MRI scanning company, has raised $120 million to advance preventative health. Its backers include Nest founder Tony Fadell, former Google CEO Eric Schmidt, model Cindy Crawford, and 23AndMe CEO Anne Wojcicki, alongside venture firms Felicis and Forerunner, according to the Prenuvo newsroom. Forerunner, founded in 2012, has raised nearly $3 billion in assets under management and sits on the cap tables of Oura, Chime, Hims & Hers, and Glossier, a portfolio that reads like a map of the wellness-meets-consumer crossover.
The product mix inside the category is shifting, too. Full-body screening accounted for 42.5% of health check-up market share in 2024, per Mordor Intelligence, with AI-driven full-body scans forecast to post the highest growth rate in the segment at a 4.2% CAGR through 2030. That is the territory Prenuvo and Ezra are competing in, and it sits some distance from a Fitbit on your wrist.
From Hardware to Service: The Commercial Logic
The webinar will look at how companies across the category are moving beyond the device itself. Oura, whose ring has become something of a status object in wellness circles, and Whoop are both building subscription and data layers on top of their hardware. Neko Health and Ezra are betting on clinic networks and recurring scan models. The common thread is recurring revenue and personalisation, which should feel familiar to anyone who has watched luxury fashion wrestle with the same pivot.
For fashion and luxury executives, the appeal is partly aspirational alignment. Consumers spending on preventative health and continuous monitoring tend to overlap with consumers spending on premium product. The category also raises pointed questions for brands: do you partner, invest, co-brand, or simply watch while a health-tracking ring becomes the most data-rich object your customer owns?
The webinar is open to all Vogue Business members. Executive Members get a further session: an exclusive virtual roundtable on 22 September, where O’Brien will host a smaller-group discussion for those who want to move from briefing to strategy. For anyone trying to get ahead of where longevity tech for fashion executives intersects with actual commercial opportunity, that is probably the more useful room to be in.
